Reuters reveals how COVID-19’s long-term toll signals billions in healthcare costs ahead

Reuters took readers on a deep dive into how studies of COVID-19 patients keep uncovering new complications associated with the disease. With mounting evidence that some COVID-19 survivors face months, or possibly years, of debilitating complications, healthcare experts are beginning to study possible long-term costs and considering whether these long-term effects can be considered a “post-COVID syndrome.”